Talphera, Inc. ( (TLPH) ) has released its Q3 earnings. Here is a breakdown of the information Talphera, Inc. presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for medically supervised settings, with a notable emphasis on its lead product candidate, Niyad, which is under investigation as an anticoagulant for extracorporeal circuits.